<--- Back to Details
First PageDocument Content
Pharmacology / Health / Pharmaceuticals policy / Pharmaceutical industry / Drug safety / New Drug Application / Prescription Drug User Fee Act / Pharmacovigilance / Rosiglitazone / Pharmaceutical sciences / Food and Drug Administration / Medicine
Date: 2002-09-18 17:34:54
Pharmacology
Health
Pharmaceuticals policy
Pharmaceutical industry
Drug safety
New Drug Application
Prescription Drug User Fee Act
Pharmacovigilance
Rosiglitazone
Pharmaceutical sciences
Food and Drug Administration
Medicine

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 382,11 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xvUb - View Document

PDF Document

DocID: 1xc8R - View Document

Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME

DocID: 1vqsj - View Document

Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia

DocID: 1vlJU - View Document

Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology

DocID: 1vk1K - View Document